IS:DIVISLAB Divi's Laboratories Limited

Divi's Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates for generics in India. The company also offers building blocks for peptide and nucleotides; carotenoids, including apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; nutraceuticals; protected amino acids, such as BOC, FMOC, and CBZ; and chiral ligands. In addition, it undertakes custom synthesis of APIs and advanced intermediates for discovery compounds for pharma companies; and full time equivalent/contract research on process development for discovering new compounds. It operates in Europe, Asia, the United States, and internationally. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

4,630.35 INR
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  03/12/2003
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   1,225,564,225,536 INR
Current dividend yield:   0.44%
Sedol:      6602518

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy